At Ease USA (AEU) is committed to providing access to confidential trauma treatment and therapeutic support for active military, veterans and their loved ones, regardless of their ability to pay. AEU complements existing services offered by military and veterans organizations, with a focus on the elimination of barriers to treatment for those suffering from the effects of deployment and the uncertainty of war.
There are three At Ease USA-funded clinics in Nebraska – Bellevue, Grand Island and North Platte. Services are also provided in Lincoln. In addition to one-on-one therapy, At Ease also includes peer-to-peer group therapy and support sessions, both for veterans and family members. Clients are offered individual and family sessions.
AEU also continues to partner with the Women’s Center for Advancement by funding participants in Healing Warriors. The Healing Warriors program includes crisis intervention, individualized case management, pro bono legal services, therapy, peer support groups, and self-sufficiency services for clients who are connected to the military.
One out of every five deployed troops will develop Post Traumatic Stress Disorder, many troops and their families returning to Nebraska will undoubtedly require mental health services. Many of these families live outside of Omaha and Lincoln.
AEU funded the first-ever clinical trials on Attention Control Training (ACT) in the United States. ACT is a promising, brief, computerized, behavioral intervention that has been effective in treating anxiety disorders, but had not been tested for PTSD prior to these trials. In conjunction with Creighton University, AEU has completed the trials on veterans and is wrapping up the trials on children between the ages of 7-14. The software will be launched in January 2021 for use by therapists in treating PTSD in veterans.
Through prudent financial stewardship, AEU has been able to expand critical mental health services during this global pandemic. We have hired a clinical manager, Laura Fischer, LIMHP, to train therapists to utilize the software with our military clients and possibly children experiencing PTSD because of community-related violence.
A new initiative, the Preferred Provider Network, will be launched in 2021. Through partnerships with local therapists throughout Nebraska, we will expand our reach even further to help those families in remote areas battling with the impact of multiple deployments.
At Ease has demonstrated that public-private partnerships are the quickest and most compassionate way to get veterans the help they need.
At Ease USA is 100% confidential. No one will ever know an individual has sought treatment with us unless the client authorizes us to do so. We do not require our clients to provide any form of identification, Social Security number, etc., unless they feel comfortable doing so.
At Ease USA has demonstrated that public-private partnerships are the quickest and most compassionate way to get veterans the help they need.
Less than 35% of veterans with PTSD, traumatic brain injury (TBI) or both ever pursue treatment from the VA. According to an early Report on Wounded Warriors there is a long-standing stigma within the military against admitting to psychological problems in general, and to PTSD in particular. At Ease USA is 100% privately funded without any direct ties to the Department of Defense or the Department of Veteran's Affairs.
One of the founding principles of AEU is that we will only employ the most effective practices and methods for treating PTSD as evidenced by empirical data and research. We systematically record and analyze pre- and post- treatment data for every client, using metrics most recognized in the field to ensure a superior result regarding functionality and symptoms.
Our goal is not just to constantly improve outcomes, but to continuously strive for better outcomes, faster results, and lower costs per degree of improvement. Toward that end, AEU is launching a new, cutting-edge software for attention control training. AEU partnered with Tel Aviv University to conduct the first trial in the United States and one of only two trials in the world, testing the effectiveness of ABMT on PTSD.